A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers

Inclusion Criteria: * Healthy participant aged 19 to 55 years, at screening * A participant who has a body mass index (BMI) of 18.0\~29.9 kg/m2, at screening * A participant who is judged to be eligible to participate by the results of screening tests (vital signs, clinical laboratory tests, 12-lead ECG, etc.) by the principal investigator Exclusion Criteria: * A participant who has taken drugs that induce or inhibit drug metabolizing enzymes * A participant who has participated in other clinical trials or bioequivalence studies within 6 months prior to the first dose of the investigational drug * A participant who has a history of gastrointestinal surgery that may affect drug absorption